Stock listing
Pharmaengine, Inc.
Selected listing: 4162 · TPEX · TWD · TW
Pharmaengine, Inc. (TPEx:4162), Health Technology. Latest release Sep 9, 2025: XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's…
- Ticker
- TPEx:4162
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEx
- Currency
- TWD
About Pharmaengine, Inc.
Pharmaengine, Inc. is a public company traded on the Taiwan stock market under the ticker 4162. Pharmaengine focuses on developing innovative pharmaceutical solutions to address unmet medical needs.
Latest news from Pharmaengine, Inc.
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals
September 9, 2025
PharmaEngine : Phase III RESILIENT trial evaluating Onivyde in second-line monotherapy for small cell lung cancer did not meet its primary endpoint
August 3, 2022
PharmaEngine : to attend 1H22 financial status investor conference hosted by Cathay Securities
July 26, 2022
PharmaEngine : announces the board resolutions on approving the Second Quarter of 2022 consolidated financial report
July 26, 2022
PharmaEngine : Announcement on the record date for the capital increase of Employee Restricted Shares and related matters
July 26, 2022